Mark Tangney PhD MBA

Principal Investigator, Cancer Research@UCC

                        Director, SynBio Centre, UCC

Senior Investigator, APC Microbiome Ireland, UCC 

​

Our research team is developing biologically-engineered therapeutics and diagnostics. Interests include Synthetic Biology; development of microbes as medicines; associations between bacteria and cancer; and entrepreneurship.
 I worked for a number of years at various international institutions (Los Angeles, Boston, Copenhagen) and published extensively in the fields of biological engineering. I'm Vice Secretary General of the International Society for Cell and Gene Therapy of Cancer (ISCGT); council member of the Irish Association for Cancer Research (IACR); scientific committee member of the European Society for Gene & Cell Therapy (ESGCT),  Vice-President of the Irish Society for Gene and Cell Therapy (ISGCT), and member of the editorial board of several international journals (Scientific Reports; Human Gene Therapy, Current Gene Therapy, Molecular Therapy - Oncolytics, Bioengineered, Biomarkers in Cancer).
My group's work is funded by grants awarded from the EU, Science Foundation Ireland, Health Research Board, Irish Research Council and the Irish Cancer Society.